Tetralogy of fallot diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Tetralogy of fallot}} | {{Tetralogy of fallot}} | ||
{{CMG}}; {{AE}} {{Fs}} | {{CMG}}; {{AE}} {{Fs}} | ||
== Overview == | == Overview == | ||
[[Echocardiography]] is the gold standard test for the diagnosis of tetralogy of fallot. | [[Echocardiography]] is the gold standard test for the diagnosis of tetralogy of fallot. | ||
| Line 22: | Line 23: | ||
There are no established criteria for the diagnosis of [disease name]. | There are no established criteria for the diagnosis of [disease name]. | ||
== 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines<ref name="pmid30121240">{{cite journal| author=Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM | display-authors=etal| title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | journal=J Am Coll Cardiol | year= 2019 | volume= 73 | issue= 12 | pages= 1494-1563 | pmid=30121240 | doi=10.1016/j.jacc.2018.08.1028 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30121240 }}</ref> == | |||
=== Diagnostic Recommendations for Tetralogy Of Fallot === | |||
{| class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon" |[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
| bgcolor="LemonChiffon" |'''1.'''Programmed ventricular stimulation can be useful to risk-stratify adults with TOF and additional risk factors for SCD.''(Level of Evidence: B-NR)'' | |||
|- | |||
| bgcolor="LemonChiffon" |'''2.''' In patients with repaired TOF, cardiac catheterization with angiography, if indicated, is reasonable to assess hemodynamics when adequate data cannot be obtained noninvasively in the setting of an arrhythmia, HF, unexplained ventricular dysfunction, suspected pulmonary hypertension or cyanosis. ''(Level of Evidence: C-EO)'' | |||
|} | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 05:16, 16 December 2022
|
Tetralogy of fallot Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
|
|
Tetralogy of fallot diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Tetralogy of fallot diagnostic study of choice |
|
Risk calculators and risk factors for Tetralogy of fallot diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Echocardiography is the gold standard test for the diagnosis of tetralogy of fallot.
Diagnostic Study of Choice
Study of choice
Echocardiography is the gold standard test for the diagnosis of tetralogy of fallot.[1]
Echocardiography must be performed in all neonates with <90% oxygen saturation after birth.
Diagnostic results
The following findings on performing echocardiography are confirmatory for tetralogy of fallot:
Name of Diagnostic Criteria
There are no established criteria for the diagnosis of [disease name].
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[2]
Diagnostic Recommendations for Tetralogy Of Fallot
| Class IIa |
| 1.Programmed ventricular stimulation can be useful to risk-stratify adults with TOF and additional risk factors for SCD.(Level of Evidence: B-NR) |
| 2. In patients with repaired TOF, cardiac catheterization with angiography, if indicated, is reasonable to assess hemodynamics when adequate data cannot be obtained noninvasively in the setting of an arrhythmia, HF, unexplained ventricular dysfunction, suspected pulmonary hypertension or cyanosis. (Level of Evidence: C-EO) |
References
- ↑ Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.
- ↑ Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.